b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31859056</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>13</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1879-1484</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>296</Volume>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>03</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Atherosclerosis</Title>\n                <ISOAbbreviation>Atherosclerosis</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Changes in vascular calcification and bone mineral density in calcium supplement users from the Canadian Multi-center Osteoporosis Study (CaMOS).</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>83-90</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0021-9150(19)31609-0</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.atherosclerosis.2019.12.003</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND AND AIMS">Calcium supplements have been associated with increased cardiovascular events. This study investigates the relationship between calcium supplement use and the 5 year progression of abdominal aorta calcification (AAC) in participants from one center of the Canadian Multi-Centre Osteoporosis Study (CaMOS).</AbstractText>\n                <AbstractText Label="METHODS">Participants (n\xc2\xa0=\xc2\xa0296; 217 women and 79 men) had lateral spine X-rays and DEXA bone mineral density (BMD) scans (femoral neck, lumbar spine and total hip) taken at two time points within a 5 year interval. AAC was assessed using the Framingham Method. Calcium supplement use was assessed by a facilitated health history questionnaire and medication inventory.</AbstractText>\n                <AbstractText Label="RESULTS">AAC significantly increased over 5 years, AAC progression was significantly greater in calcium supplement users, as compared to non-users, overall and in females. The amount of calcium was positively correlated to AAC progression. A multi-variable linear regression model was generated for women only, as there were not enough men for multivariable modelling. Calcium supplement use and amount remained significantly associated with AAC progression after adjustment for age, hypertension, diabetes and smoking history. Change in AAC score was not associated with change in BMD T-Score. In univariate analyses of males, calcium supplement use was associated with a significantly greater BMD loss at the lumbar spine, hip, and femoral neck.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">Older female calcium supplement users had significantly higher AAC progression over 5 years, but did not have any significant BMD preservation. These results suggest that vascular calcification may contribute to the cardiovascular events observed in calcium supplement users.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Hulbert</LastName>\n                    <ForeName>Maggie</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Queen\'s University, 94 Stuart St, Kingston, ON, K7L 2V6, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Turner</LastName>\n                    <ForeName>Mandy E</ForeName>\n                    <Initials>ME</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biomedical and Molecular Science, Queen\'s University, 18 Stuart St, Kingston, ON, K7L 3N6, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hopman</LastName>\n                    <ForeName>Wilma M</ForeName>\n                    <Initials>WM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Kingston General Health Research Institute, 76 Stuart St, Kingston Health Sciences Centre, Kingston, ON, K7L 2V7, Canada; Department of Public Health Sciences, Queen\'s University,62 Fifth Field Company Lane, Kingston, ON, K7L 3L3, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Anastassiades</LastName>\n                    <ForeName>Tassos</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Queen\'s University, 94 Stuart St, Kingston, ON, K7L 2V6, Canada; Department of Biomedical and Molecular Science, Queen\'s University, 18 Stuart St, Kingston, ON, K7L 3N6, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Adams</LastName>\n                    <ForeName>Michael A</ForeName>\n                    <Initials>MA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biomedical and Molecular Science, Queen\'s University, 18 Stuart St, Kingston, ON, K7L 3N6, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Holden</LastName>\n                    <ForeName>Rachel M</ForeName>\n                    <Initials>RM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Queen\'s University, 94 Stuart St, Kingston, ON, K7L 2V6, Canada; Department of Biomedical and Molecular Science, Queen\'s University, 18 Stuart St, Kingston, ON, K7L 3N6, Canada. Electronic address: Rachel.holden@kingstonhsc.ca.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>16</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Ireland</Country>\n            <MedlineTA>Atherosclerosis</MedlineTA>\n            <NlmUniqueID>0242543</NlmUniqueID>\n            <ISSNLinking>0021-9150</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">CaMOS</Keyword>\n            <Keyword MajorTopicYN="Y">Calcium supplementation</Keyword>\n            <Keyword MajorTopicYN="Y">Vascular calcification</Keyword>\n        </KeywordList>\n        <CoiStatement>Declaration of competing interest Maggie Hulbert, Mandy Turner, Wilma Hopman, Tassos Anastassiades, Michael Adams and Rachel Holden declare that they have no conflict of interest.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>06</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31859056</ArticleId>\n            <ArticleId IdType="pii">S0021-9150(19)31609-0</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.atherosclerosis.2019.12.003</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'